In the Apcmin/+ model, supplementation with KLK1 significantly inhibited adenoma formation, reduced epithelial dysplasia, and downregulated pro‐oncogenes such as Mmp2, Mmp9, Fap, Dcn, and Ctnnb1. The gene discussed is KLK1; the disease is adenoma.